Chemoinformaics analysis of Methyl 2,6-dimethoxybenzoate
Molecular Weight | 196.202 | nRot | 3 |
Heavy Atom Molecular Weight | 184.106 | nRig | 7 |
Exact Molecular Weight | 196.074 | nRing | 1 |
Solubility: LogS | -2.314 | nHRing | 0 |
Solubility: LogP | 1.368 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 27.9095 |
nHD | 0 | BPOL | 18.1145 |
QED | 0.687 |
Synth | 1.584 |
Natural Product Likeliness | -0.102 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.017 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.487 |
MDCK | 0.0000317 |
BBB | 0.938 |
PPB | 0.420149 |
VDSS | 0.866 |
FU | 0.233151 |
CYP1A2-inh | 0.98 |
CYP1A2-sub | 0.95 |
CYP2c19-inh | 0.802 |
CYP2c19-sub | 0.884 |
CYP2c9-inh | 0.176 |
CYP2c9-sub | 0.858 |
CYP2d6-inh | 0.059 |
CYP2d6-sub | 0.902 |
CYP3a4-inh | 0.3 |
CYP3a4-sub | 0.412 |
CL | 9.06 |
T12 | 0.752 |
hERG | 0.109 |
Ames | 0.14 |
ROA | 0.055 |
SkinSen | 0.307 |
Carcinogencity | 0.065 |
EI | 0.977 |
Respiratory | 0.313 |
NR-Aromatase | 0.045 |
Antiviral | No |
Prediction | 0.858537 |